Skip to content

LLETZ Under General Versus Local Anesthesia

Large Loop Excision of the Transformatione Zone Under General Versus Local Anesthesia: a Randomized Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03494686
Enrollment
229
Registered
2018-04-11
Start date
2018-04-03
Completion date
2020-03-14
Last updated
2020-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine Cervical Dysplasia

Keywords

conization, LLETZ, randomized controlled trial, loop excision, general anaesthesia, local anaesthesia

Brief summary

The investigators conduct a prospective, randomized trial to assess the benefits of performing large loop excision of the transformatione zone (LLETZ) under local anesthesia and compare it to LLETZ under general anesthesia. The primary endpoint of this study is women´s satisfaction.

Interventions

PROCEDURELLETZ under local anaesthesia

Conization will be performed under local anaesthesia

PROCEDURELLETZ under general anaesthesia

Conization will be performed under general anaesthesia

Sponsors

Zydolab - Institute of Cytology and Immune Cytochemistry
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* colposcopy Prior to conization * informed consent * histologically proven high grade cervical dysplasia * Transformation zone typ 1 or 2

Exclusion criteria

* significant language barrier * a personal history of conization * pregnancy * the use of blood thinner * unwillingness to participate * oncological disease * inpatient treatment * women who are not fasting * risk of aspiration * columnar-squamous epithelium border not fully visible

Design outcomes

Primary

MeasureTime frameDescription
Womens satisfaction2 hoursPatients will score their satisfaction by using a 11-step visual analogue scale (VAS) ranging from '0' (not satisfied at all) to '10' (very satisfied) 2 hours after Treatment

Secondary

MeasureTime frameDescription
the resected cone mass10 minutesthe resected cone mass will be quantified by weighing the removed tissue with a precision scale located in the operating room
Operation time20 minutesthe time from the beginning of the Operation (start of the electrosurgical method) until the end of the operation (the end of hemostatic interventions) will be measured in minutes
Operative complications14 daysOperative complications defined as necessity to intervene therapeutically up to 14 days postoperatively
Margin status2 days after conizationResection margin is judge as R0 if abnormal cells are not found in the margin of the biopsy or R1 if abnormal cells remain in the margin of the biopsy. The histopathological examination will be done by an Independent pathologist
Postoperative pain2 hourspatients will score their postoperative pain Level using a 11-step visual analogue scale (VAS) ranging from '0' (no pain ) to '10' (maximum pain) within 2 hours after surgery
Surgeons satisfaction20 minutesSurgeons will score their satisfaction by using a 11-step visual analogue scale (VAS) 20 minutes after Treatment
number of fragments of the surgical specimen20 minutessurgeons will count the number of the surgical specimen (1 vs. \>1)
Intraoperative blood loss5 hoursintraoperative blood loss will be measured using the difference in serum hemoglobin one day prior to surgery and within 5 hours postoperatively
the dimensions of the surgical specimens20 minutesThe circumference, length and thickness of The surgical specimens will be measured
Time to complete intraoperative hemostasis120 secondsthe time until complete hemostasis as judged by the surgeon has been achieved, will be measured in seconds

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026